The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma
Abstract
BACKGROUND: An effective, long-acting bronchodilator could benefit patients with asthma who have symptoms not controlled by antiinflammatory drugs. We compared a new long-acting, inhaled beta 2-adrenoceptor agonist, salmeterol, with a short-acting beta 2-agonist, albuterol, in the treatment of mild-to-moderate asthma. METHODS: We randomly assigned 234 patients (150 male and 84 female patients 12 to 73 years old) to one of three treatment groups: one group received 42 micrograms of salmeterol twice daily, one received 180 micrograms of albuterol four times daily, and one received placebo. Treatment was assigned in a double-blind fashion, and all patients could use supplemental inhaled albuterol as needed during the 12-week treatment period. RESULTS: Measurements of the forced expiratory volume in one second, performed hourly for 12 consecutive hours, showed that a single dose of salmeterol produced a greater mean area under the curve than two doses of albuterol taken 6 hours apart (6.3 vs. 4.9 liter.hr, P < 0.05). The difference was significant on day 1 and at week 4 of the study, but not at week 8 or 12. Salmeterol was also more effective than albuterol or placebo (with albuterol taken as needed) in increasing the morning peak expiratory flow rate: salmeterol induced a mean increase of 24 liters per minute over the pretreatment values, as compared with a decrease of 6 liters per minute with albuterol (P < 0.001) and an increase of 1 liter per minute with placebo (P = 0.002). The mean overall symptom score was improved most by salmeterol treatment (P < 0.05), with the number of days with symptoms and of nights with awakenings decreasing by 22 percent and 52 percent, respectively; there were no differences in results between albuterol treatment and placebo administration. We found no evidence of tolerance to the bronchodilating effects of salmeterol, and adverse reactions to all the treatments were infrequent and mild. CONCLUSIONS: For the management of mild-to-moderate asthma, salmeterol given twice daily is superior to albuterol given either four times daily or as needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.1.225 · Cited by 2,234
Regular inhaled beta-agonist treatment in bronchial asthma
Sears, M. R., Taylor, D. R., Print, C. G., Lake, D. C., Li, Q., Flannery, E. M., Yates, D. M., Lucas, M. K., & Herbison, G. P. (1990) · The Lancet · doi:10.1016/0140-6736(90)93098-a · Cited by 1,065
Pulmonary Function Testing in Children. Techniques and Standards
(1973) · Clinical Pediatrics · doi:10.1177/000992287301200517 · Cited by 761
A New Approach to the Treatment of Asthma
Oates, J. A., Wood, A. J. J., & Barnes, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212206 · Cited by 450
Protection against allergen-induced asthma by salmeterol
Twentyman, O. P., Finnerty, J. P., Holgate, S. T., Harris, A., & Palmer, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)92894-n · Cited by 231
Ball, D. I., Brittain, R. T., Coleman, R. A., Denyer, L. H., Jack, D., Johnson, M., Lunts, L. H. C., Nials, A. T., Sheldrick, K. E., & Skidmore, I. F. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12486.x · Cited by 185
Ullman, A., Hedner, J., & Svedmyr, N. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.3.571 · Cited by 162
Malo, J., Ghezzo, H., Trudeau, C., L’Archevêque, J., & Cartier, A. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90324-u · Cited by 53
Cited by
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Global strategy for asthma management and prevention: GINA executive summary
Bateman, E. D., Hurd, S. S., Barnes, P. J., Bousquet, J., Drazen, J. M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S. E., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00138707 · Cited by 3,203
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
Pauwels, R. A., Löfdahl, C.-G., Postma, D. S., Tattersfield, A. E., O'Byrne, P., Barnes, P. J., & Ullman, A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711133372001 · Cited by 1,520
National Asthma Education and Prevention Program
VanGraafeiland, B. (2002) · The Nurse Practitioner · doi:10.1097/00006205-200206001-00003 · Cited by 1,091
Greening, A. P., Ind, P. W., Northfield, M., & Shaw, G. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92996-3 · Cited by 972
Metadata
- Authors
- Pearlman, D. S., Chervinsky, P., LaForce, C., Seltzer, J. M., Southern, D. L., Kemp, J. P., Dockhorn, R. J., Grossman, J., Liddle, R. F., Yancey, S. W., Cocchetto, D. M., Alexander, W. J., & van As, A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1992-11-12
- Volume
- 327
- Issue
- 20
- Pages
- 1420-1425
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2336268573
- Cited by
- 362
- References
- 8
- FWCI
- 11.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma. https://app.cochat.ai/papers/10.1056/nejm199211123272004
- The paper
- Pearlman, D. S., Chervinsky, P., LaForce, C., Seltzer, J. M., Southern, D. L., Kemp, J. P., Dockhorn, R. J., Grossman, J., Liddle, R. F., Yancey, S. W., Cocchetto, D. M., Alexander, W. J., & van As, A. (1992). A Comparison of Salmeterol with Albuterol in the Treatment of Mild-to-Moderate Asthma. New England Journal of Medicine. https://doi.org/10.1056/nejm199211123272004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.